secwatch / observer
8-K filed December 4, 2023, 6:59 PM ET ticker RTGN CIK 0001836295
leadership confidence high sentiment neutral materiality 0.40

RetinalGenix appoints Virender Ahluwalia as Interim CFO; $300/hr, $15k base contingent on capital

RetinalGenix Technologies Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Virender Ahluwalia

Interim Chief Financial Officer
RTGN · RetinalGenix Technologies Inc.
Effective
2023-11-30
Filed
December 4, 2023, 6:59 PM ET
On November 30, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Virender Ahluwalia to serve as Interim Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Virender Ahluwalia was appointed as Interim Chief Financial Officer at RetinalGenix Technologies Inc..

Action
appointed
Role
Interim Chief Financial Officer
Exact text from the filing
On November 30, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Virender Ahluwalia to serve as Interim Chief Financial Officer of the Company.
View on SEC.gov

RetinalGenix Technologies Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-043522
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.